investorscraft@gmail.com

Intrinsic ValueLifeway Foods, Inc. (LWAY)

Previous Close$22.03
Intrinsic Value
Upside potential
Previous Close
$22.03

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Lifeway Foods, Inc. operates in the dairy and probiotic food products industry, specializing in kefir and other cultured dairy products. The company generates revenue primarily through the production and distribution of its branded and private-label products, sold via retail, foodservice, and e-commerce channels. Lifeway has carved a niche in the health-conscious consumer segment, leveraging the growing demand for functional foods that support gut health and immunity. Its market position is bolstered by a vertically integrated supply chain, proprietary fermentation processes, and a strong distribution network across North America. The company competes with both large dairy conglomerates and smaller organic brands, differentiating itself through product innovation and a focus on organic, non-GMO, and probiotic-rich offerings. Lifeway’s strategic partnerships with major retailers and expansion into plant-based alternatives further strengthen its competitive edge in the evolving health food sector.

Revenue Profitability And Efficiency

Lifeway Foods reported revenue of $186.8 million for the fiscal year ending December 31, 2024, with net income of $9.0 million, translating to a diluted EPS of $0.59. Operating cash flow stood at $13.0 million, reflecting efficient working capital management. Capital expenditures of $6.7 million indicate ongoing investments in production capacity and innovation, supporting long-term growth.

Earnings Power And Capital Efficiency

The company demonstrates solid earnings power, with a net margin of approximately 4.8%. Its capital efficiency is evident in its ability to generate positive operating cash flow while maintaining modest debt levels. The absence of significant leverage allows Lifeway to reinvest in growth initiatives without undue financial strain.

Balance Sheet And Financial Health

Lifeway’s balance sheet remains robust, with $16.7 million in cash and equivalents and minimal total debt of $117,000. This strong liquidity position provides flexibility for strategic investments or potential acquisitions. The company’s low debt-to-equity ratio underscores its financial stability and low-risk profile.

Growth Trends And Dividend Policy

Lifeway has shown consistent revenue growth, driven by increasing consumer demand for probiotic-rich foods. The company does not currently pay dividends, opting instead to reinvest profits into expansion and product development. This aligns with its growth-focused strategy and the dynamic nature of the health food market.

Valuation And Market Expectations

With a market capitalization derived from its share price and 14.8 million shares outstanding, Lifeway’s valuation reflects investor confidence in its niche market positioning and growth potential. The absence of dividends suggests the market anticipates future earnings growth and capital appreciation.

Strategic Advantages And Outlook

Lifeway’s strategic advantages include its strong brand recognition, proprietary fermentation technology, and diversified distribution channels. The outlook remains positive, supported by trends favoring functional foods and the company’s ability to innovate. Challenges include competitive pressures and input cost volatility, but Lifeway’s focus on premium, health-focused products positions it well for sustained growth.

Sources

Company filings (10-K), investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount